Biotech

All Articles

A better consider Tough Biotech's Strong 15

.Within this week's incident of "The Best Line," we are actually diving in to Ferocious Biotech's ye...

Lilly faces phase 2 breakdown of tau-targeting med

.The confetti is actually still flying from Eli Lilly's party celebrating the commendation of Alzhei...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of significant management hirings, firings and r...

Lykos will definitely ask FDA to reconsider its own choice adhering to turndown of MDMA therapy for trauma

.Adhering to a poor showing for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorde...

AN 2 fifty percents head count, ceases stage 3 test after records disappoint

.AN2 Rehabs is actually reassessing its company in action to dull midphase data, swearing to give up...

Merck spends $700M for bispecific, spying autoimmune position as well as chance to challenge Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer cell...

Gilead spends J&ampJ $320M to exit licensing bargain for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its own liver condition medicine seladelpa...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may observe the companies putting together camping tents at bas...

Entero giving up personnel, abandoning office and also pausing R&ampD

.Mattress Liquidators has actually turned Entero Therapies white colored as a piece. The financial i...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is losing hope on its tissue factor (TF)- targeting antibody-drug conjugate after concludi...